[go: up one dir, main page]

PL2139455T3 - Tabletka o ulepszonej stabilności zawierająca co najmniej dwie substancje czynne - Google Patents

Tabletka o ulepszonej stabilności zawierająca co najmniej dwie substancje czynne

Info

Publication number
PL2139455T3
PL2139455T3 PL08718773T PL08718773T PL2139455T3 PL 2139455 T3 PL2139455 T3 PL 2139455T3 PL 08718773 T PL08718773 T PL 08718773T PL 08718773 T PL08718773 T PL 08718773T PL 2139455 T3 PL2139455 T3 PL 2139455T3
Authority
PL
Poland
Prior art keywords
tablet
active substances
improved stability
stability containing
improved
Prior art date
Application number
PL08718773T
Other languages
English (en)
Inventor
Huw Jones
Gurmeet Rajput
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of PL2139455T3 publication Critical patent/PL2139455T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
PL08718773T 2007-03-24 2008-03-19 Tabletka o ulepszonej stabilności zawierająca co najmniej dwie substancje czynne PL2139455T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0705714A GB2447898B (en) 2007-03-24 2007-03-24 A tablet having improved stability with at least two actives
EP08718773.8A EP2139455B1 (en) 2007-03-24 2008-03-19 A tablet having improved stability with at least two actives
PCT/GB2008/000933 WO2008117018A2 (en) 2007-03-24 2008-03-19 A tablet having improved stability with at least two actives

Publications (1)

Publication Number Publication Date
PL2139455T3 true PL2139455T3 (pl) 2019-05-31

Family

ID=38024799

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08718773T PL2139455T3 (pl) 2007-03-24 2008-03-19 Tabletka o ulepszonej stabilności zawierająca co najmniej dwie substancje czynne

Country Status (14)

Country Link
US (1) US20100152173A1 (pl)
EP (1) EP2139455B1 (pl)
KR (1) KR101466331B1 (pl)
CN (1) CN101641085B (pl)
AU (1) AU2008231626B2 (pl)
BR (1) BRPI0809094B8 (pl)
GB (1) GB2447898B (pl)
MX (1) MX2009010231A (pl)
MY (1) MY146596A (pl)
PL (1) PL2139455T3 (pl)
RU (2) RU2498794C2 (pl)
TW (1) TW200902088A (pl)
WO (1) WO2008117018A2 (pl)
ZA (1) ZA200907384B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0909680D0 (en) 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
EP2853262B1 (en) 2009-10-26 2016-11-30 Sephoris Pharmaceuticals, LLC Treatment of sunburn using analgesics and antihistamines
US9901540B2 (en) 2010-05-10 2018-02-27 Euro-Celtique S.A. Combination of active loaded granules with additional actives
SE1251371A1 (sv) 2010-05-10 2012-12-27 Euro Celtique Sa Farmaceutiska kompositioner innefattande hydromorfon och naloxon
EP2568968B1 (en) 2010-05-10 2017-07-12 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
CN102488681B (zh) * 2011-12-21 2013-03-13 西南大学 布洛芬苯海拉明口腔崩解片及其制备方法
US9814710B2 (en) 2013-11-13 2017-11-14 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
WO2016130094A1 (en) 2015-02-10 2016-08-18 PHARMACTlVE ILAÇ SANAYI VE TlCARET A.Ş. A pharmaceutical composition containing ibuprofen, pseudoephedrine and vitamin c
CN107735080B (zh) * 2015-07-03 2020-10-23 浙江海正药业股份有限公司 一种人参皂苷c-k口服固体制剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms
AU676315B2 (en) * 1993-06-30 1997-03-06 Takeda Chemical Industries Ltd. Stabilized solid pharmaceutical preparation and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19509805A1 (de) * 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
RU2246294C2 (ru) * 1999-12-09 2005-02-20 Дзе Бутс Компани ПЛС Терапевтические средства
US20020177626A1 (en) * 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
WO2006122021A1 (en) * 2005-05-10 2006-11-16 Novartis Ag Extrusion process for making compositions with poorly compressible therapeutic compounds
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
MX2009010231A (es) 2009-12-15
KR20090125838A (ko) 2009-12-07
MY146596A (en) 2012-08-30
AU2008231626B2 (en) 2013-03-07
AU2008231626A1 (en) 2008-10-02
CN101641085B (zh) 2012-06-27
GB2447898B (en) 2011-08-17
RU2009139260A (ru) 2011-05-10
US20100152173A1 (en) 2010-06-17
GB0705714D0 (en) 2007-05-02
RU2498794C2 (ru) 2013-11-20
RU2013134474A (ru) 2015-01-27
ZA200907384B (en) 2010-12-29
EP2139455B1 (en) 2018-12-19
WO2008117018A3 (en) 2009-03-12
GB2447898A (en) 2008-10-01
BRPI0809094B8 (pt) 2021-05-25
TW200902088A (en) 2009-01-16
BRPI0809094B1 (pt) 2020-05-05
EP2139455A2 (en) 2010-01-06
KR101466331B1 (ko) 2014-11-27
CN101641085A (zh) 2010-02-03
WO2008117018A2 (en) 2008-10-02
BRPI0809094A2 (pt) 2014-09-09

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
HRP20250383T3 (hr) Tablete koje sadrže eltrombopag olamin
BRPI0821474A2 (pt) formulação farmacêutica líquida estável
DE602007008562D1 (de) Flüssigkeitsausgabespritze
DK2151438T3 (da) Lægemiddel indeholdende PPAR-Deltaagonist
EP1992348A4 (en) PHARMACEUTICAL COMBINATION
PL2114790T3 (pl) Pochłanianie tlenu
DK2343071T3 (da) Farmaceutiske doseringsformer
BRPI0920521A2 (pt) combinação farmacêutica
BRPI0812354A2 (pt) Composição farmacêutica não-aquosa.
ATE493119T1 (de) Pharmazeutische zusammensetzung
PL2139455T3 (pl) Tabletka o ulepszonej stabilności zawierająca co najmniej dwie substancje czynne
BRPI0809661A2 (pt) Composição farmacêutica estabilizada contendo pregabalina
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
SI2370327T1 (sl) Kartuša, farmacevtski razdeljevalnik, ki omenjeno kartušo vsebuje in uporabe omenjene kartuše in omenjenega farmacevtskga razdeljevalnika
EP2164759A4 (en) CELL-CONTAINING CONTAINER
BRPI0817833A2 (pt) Composição farmacêutica antimalárica
DK2027150T3 (da) Allo-begrænsede peptid-specifikke t-celler
EP1987825A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING OSELTAMIVIR PHOSPHATE
DK2131818T3 (da) Ny doseringsform
FR2919582B1 (fr) Element de stockage de liquide
BRPI0809684A2 (pt) Embalagem, e embalagem
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
BRPI0716049A2 (pt) dispersÕes de nanourÉias, contendo substÂncias ativas